Resources for Healthcare Professionals
The following resources may be helpful to your practice
Learn about ERLEADA® in the treatment of mCSPC. Review efficacy and safety data from the TITAN clinical trial.
mCSPC = metastatic castration-sensitive prostate cancer; PSA = prostate-specific antigen; SPARTAN = Selective Prostate Androgen Receptor Targeting with ARN-509; TITAN = Targeted Investigational Treatment Analysis of Novel Antiandrogen.